Saxenda (liraglutide) Saxenda (liraglutide) is a GLP-1 medication that is prescribed for weight loss
Side effects can persist after a dose change Because GLP1 levels taper gradually rather than dropping to zero, symptoms can continue for days or even weeks after a dose change
You need a concentration that works at both your starting dose and your eventual maintenance dose
Viljoen, Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
GLP-1 medications address several of these pathways simultaneously, and stopping treatment may allow the underlying PCOS-driven metabolic dysfunction to reassert itself
At Somerset Medical, we continually explore ways to provide our patients with the most effective, evidence-based care possible